头部公募密集举牌港股创新药
2026-07-22 00:26:41
据界面新闻报道，近日易方达基金、华夏基金、富国基金、汇添富基金等多家头部公募密集举牌港股创新药标的，百奥赛图-B、三生制药、石药集团、科伦博泰生物4只个股获增持后持股比例触及或超过5%的法定举牌线。与此同时，恒生创新药指数自6月底以来已累计反弹逾20%。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
中信建投：关注医疗器械加仓机会Next article：
韩国KOSPI早盘涨超5%重回7000
